Association between metabolic dysfunction-associated steatotic liver disease and risk of urolithiasis: an updated systematic review and meta-analysis.

Autor: Mantovani A; Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Verona, Verona, Italy., Morandin R; Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Verona, Verona, Italy., Fiorio V; Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Verona, Verona, Italy., Lando MG; Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Verona, Verona, Italy., Petta S; Section of Gastroenterology and Hepatology, PROMISE, University of Palermo, Palermo, Italy., Ferraro PM; Section of Nephrology, Department of Medicine, University of Verona, Verona, Italy., Targher G; Department of Medicine, University of Verona, Verona, Italy. giovanni.targher@univr.it.; Metabolic Diseases Research Unit, IRCCS Sacro Cuore, Don Calabria Hospital, Viale Luigi Rizzardi, 4, 37024, Negrar di Valpolicella (VR), Italy. giovanni.targher@univr.it.
Jazyk: angličtina
Zdroj: Internal and emergency medicine [Intern Emerg Med] 2024 Sep; Vol. 19 (6), pp. 1745-1755. Date of Electronic Publication: 2024 Jul 11.
DOI: 10.1007/s11739-024-03705-5
Abstrakt: Epidemiological studies have reported an association between metabolic dysfunction-associated steatotic liver disease (MASLD) and the risk of urolithiasis. However, the magnitude of the risk and whether this risk varies with the severity of MASLD remains uncertain. We performed a meta-analysis of observational studies to quantify the magnitude of the association between MASLD and urolithiasis. We systematically searched PubMed, Scopus, and Web of Science from database inception to March 31, 2024, using predefined keywords to identify relevant observational studies in which imaging methods or survey questionnaires diagnosed MASLD and urolithiasis. Meta-analysis was performed using random-effects modelling. We identified seven cross-sectional studies and one prospective cohort study with aggregate data on 248,936 adults from different countries. MASLD was significantly associated with an increased risk of prevalent urolithiasis (pooled random-effects odds ratio 1.87, 95% CI 1.34-2.60; I 2  = 91%). This association remained significant in those studies whose results were adjusted for age, sex, ethnicity, obesity, diabetes, and other potential confounders. There was a positive graded association between the ultrasonographic severity of MASLD and urolithiasis. Meta-analysis of the single prospective cohort study showed that MAFLD was not associated with risk of developing incident urolithiasis (pooled random-effects hazard ratio 1.08, 95% CI 0.90-1.30), although a significant association was reported in men. Sensitivity analyses did not modify these findings. The funnel plot did not reveal any significant publication bias. This updated meta-analysis provides evidence for a significant association between MASLD and the presence of urolithiasis. Whether MASLD is associated with a higher risk of developing incident urolithiasis remains to be established.
(© 2024. The Author(s).)
Databáze: MEDLINE
Externí odkaz: